{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:52:00Z","timestamp":1769111520995,"version":"3.49.0"},"reference-count":316,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cvr\/cvab343","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T01:34:33Z","timestamp":1638668073000},"page":"1618-1666","source":"Crossref","is-referenced-by-count":32,"title":["ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2\u2014care pathways, treatment, and follow-up"],"prefix":"10.1093","volume":"118","author":[{"name":"The Task Force for the management of COVID-19 of the European Society of Cardiology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Andreini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Arbelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L","family":"Bartorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Baumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elijah R","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaide","family":"Chieffo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"de Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Elvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederick","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz J","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Haude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrikus A","family":"Klok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros V","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josepa","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuccia","family":"Morici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Sonia","family":"Petronio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija M","family":"Polovina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Praz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Pruszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Rodr\u00edguez-Leor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"Scherrenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco R","family":"Spera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luccia","family":"Torracca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhian M","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur A","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2022062212370106200_cvab343-B1","doi-asserted-by":"crossref","first-page":"S720","DOI":"10.1161\/CIRCULATIONAHA.110.970970","article-title":"Part 7: CPR techniques and devices: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"122","author":"Cave","year":"2010","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0300-9572(03)00037-6","article-title":"Reverse CPR: a pilot study of CPR in the prone position","volume":"57","author":"Mazer","year":"2003","journal-title":"Resuscitation"},{"key":"2022062212370106200_cvab343-B3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00134-018-5214-9","article-title":"Management of cardiogenic shock complicating myocardial infarction","volume":"44","author":"Mebazaa","year":"2018","journal-title":"Intensive Care Med"},{"key":"2022062212370106200_cvab343-B7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.resuscitation.2017.12.007","article-title":"European Resuscitation Council Guidelines for Resuscitation: 2017 update","volume":"123","author":"Perkins","year":"2018","journal-title":"Resuscitation"},{"key":"2022062212370106200_cvab343-B9","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1503\/cmaj.060911","article-title":"Development of a triage protocol for critical care during an influenza pandemic","volume":"175","author":"Christian","year":"2006","journal-title":"CMAJ"},{"key":"2022062212370106200_cvab343-B11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/jcm9020575","article-title":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China","volume":"9","author":"Deng","year":"2020","journal-title":"J Clin Med"},{"key":"2022062212370106200_cvab343-B12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2020.07.022","article-title":"High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction","volume":"76","author":"Choudry","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","article-title":"Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era","volume":"41","author":"De Rosa","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4244\/EIJ-D-20-00935","article-title":"In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19","volume":"16","author":"Rodriguez-Leor","year":"2021","journal-title":"EuroIntervention"},{"key":"2022062212370106200_cvab343-B15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/CIRCULATIONAHA.120.047070","article-title":"Critical organizational issues for cardiologists in the COVID-19 outbreak: a frontline experience from Milan, Italy","volume":"141","author":"Stefanini","year":"2020","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/heartjnl-2020-317186","article-title":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"key":"2022062212370106200_cvab343-B18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/heartjnl-2020-317322","article-title":"Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19","volume":"106","author":"Stefanini","year":"2020","journal-title":"Heart"},{"key":"2022062212370106200_cvab343-B19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1473-3099(20)30144-4","article-title":"Early dynamics of transmission and control of COVID-19: a mathematical modelling study","volume":"20","author":"Kucharski","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2022062212370106200_cvab343-B20","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jcmg.2020.04.012","article-title":"\u201cQuadruple rule-out\u201d with computed tomography in a COVID-19 patient with equivocal acute coronary syndrome presentation","volume":"13","author":"Pontone","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022062212370106200_cvab343-B21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-016-9973-1","article-title":"Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia: a cohort study","volume":"195","author":"Basille","year":"2017","journal-title":"Lung"},{"key":"2022062212370106200_cvab343-B22","doi-asserted-by":"crossref","first-page":"d1642","DOI":"10.1136\/bmj.d1642","article-title":"Effect of statin treatment on short term mortality after pneumonia episode: cohort study","volume":"342","author":"Douglas","year":"2011","journal-title":"BMJ"},{"key":"2022062212370106200_cvab343-B23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1017\/S0950268810000105","article-title":"An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006","volume":"138","author":"Fleming","year":"2010","journal-title":"Epidemiol Infect"},{"key":"2022062212370106200_cvab343-B24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int"},{"key":"2022062212370106200_cvab343-B25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B27","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","article-title":"Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study","volume":"41","author":"Basso","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cardfail.2020.11.002","article-title":"Clinically suspected myocarditis in the course of severe acute respiratory syndrome novel coronavirus-2 infection: fact or fiction?","volume":"27","author":"Ozieranski","year":"2021","journal-title":"J Card Fail"},{"key":"2022062212370106200_cvab343-B29","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/ejhf.1915","article-title":"Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Zhang","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B30","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications","volume":"22","author":"Rey","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B32","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022062212370106200_cvab343-B34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.31083\/j.rcm.2020.03.129","article-title":"Critical complications of COVID-19: a descriptive meta-analysis study","volume":"21","author":"Vakili","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"2022062212370106200_cvab343-B35","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2052","article-title":"Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B36","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.jcmg.2020.04.014","article-title":"Prognostic value of right ventricular longitudinal strain in patients with COVID-19","volume":"13","author":"Li","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022062212370106200_cvab343-B37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.jcmg.2020.05.010","article-title":"Right ventricular dilation in hospitalized patients with COVID-19 infection","volume":"13","author":"Argulian","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022062212370106200_cvab343-B38","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2020.08.066","article-title":"Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19","volume":"76","author":"Kim","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2022062212370106200_cvab343-B40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pcad.2020.03.001","article-title":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","volume":"63","author":"Lippi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2022062212370106200_cvab343-B43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B44","first-page":"105","article-title":"Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry","volume":"74","author":"Lopez-Otero","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2022062212370106200_cvab343-B45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ejhf.1871","article-title":"COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B46","doi-asserted-by":"crossref","first-page":"e007274","DOI":"10.1161\/CIRCHEARTFAILURE.120.007274","article-title":"Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark: a nationwide cohort study","volume":"13","author":"Andersson","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2022062212370106200_cvab343-B47","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/ejhf.1986","article-title":"Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London","volume":"22","author":"Cannat\u00e0","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B48","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cjca.2020.07.006","article-title":"Reduced rate of hospital presentations for heart failure during the COVID-19 pandemic in Toronto, Canada","volume":"36","author":"Frankfurter","year":"2020","journal-title":"Can J Cardiol"},{"key":"2022062212370106200_cvab343-B49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ejhf.1925","article-title":"The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic","volume":"22","author":"Bromage","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B50","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ejhf.2044","article-title":"In-hospital care in acute heart failure during the COVID-19 pandemic: insights from the German-wide Helios hospital network","volume":"22","author":"Konig","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.puhe.2020.08.007","article-title":"Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece","volume":"187","author":"Oikonomou","year":"2020","journal-title":"Public Health"},{"key":"2022062212370106200_cvab343-B52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/heartjnl-2020-317912","article-title":"Place and causes of acute cardiovascular mortality during the COVID-19 pandemic","volume":"107","author":"Wu","year":"2021","journal-title":"Heart"},{"key":"2022062212370106200_cvab343-B53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B56","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"WHO Rapid Evidence Appraisal for COVID-19 Therapies Working Group","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B57","year":"2019"},{"key":"2022062212370106200_cvab343-B58","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/cvr\/cvaa160","article-title":"Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab","volume":"116","author":"Wenzel","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2022062212370106200_cvab343-B59","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.120.050097","article-title":"The enemy within: sudden-onset reversible cardiogenic shock with biopsy-proven cardiac myocyte infection by severe acute respiratory syndrome coronavirus 2","volume":"142","author":"Albert","year":"2020","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/IJCA.IJCA_40_18","article-title":"The predictors of long-term hospitalization in Turkish heart failure population: a subgroup analysis of journey heart failure-TR study: on behalf of journey heart failure-TR investigators","volume":"4","author":"Sinan","year":"2018","journal-title":"Int J Cardiovasc Acad"},{"key":"2022062212370106200_cvab343-B61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","article-title":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China","volume":"80","author":"Yang","year":"2020","journal-title":"J Infect"},{"key":"2022062212370106200_cvab343-B62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ejhf.1678","article-title":"Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"\u010celutkien\u0117","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am J Hypertens"},{"key":"2022062212370106200_cvab343-B64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/fcp.12613","article-title":"Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study","volume":"35","author":"Lafaurie","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"2022062212370106200_cvab343-B65","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ejhf.1531","article-title":"Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B66","doi-asserted-by":"crossref","first-page":"e0238281","DOI":"10.1371\/journal.pone.0238281","article-title":"Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy","volume":"15","author":"Giorgi Rossi","year":"2020","journal-title":"PLoS One"},{"key":"2022062212370106200_cvab343-B67","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.3346\/jkms.2020.35.e243","article-title":"The correlation of comorbidities on the mortality in patients with COVID-19: an observational study based on the Korean National Health Insurance Big Data","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci"},{"key":"2022062212370106200_cvab343-B68","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","article-title":"Prognostic impact of prior heart failure in patients hospitalized with COVID-19","volume":"76","author":"Alvarez-Garcia","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B69","first-page":"100665","article-title":"Changing to remote management of a community heart failure population during COVID-19\u2014clinician and patient perspectives'","volume":"31","author":"Kerr","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2022062212370106200_cvab343-B70","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/ejhf.1911","article-title":"Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre","volume":"22","author":"Salzano","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/ajt.13085","article-title":"MERS CoV infection in two renal transplant recipients: case report","volume":"15","author":"AlGhamdi","year":"2015","journal-title":"Am J Transplant"},{"key":"2022062212370106200_cvab343-B72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1034\/j.1600-6143.2003.00197.x","article-title":"Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening","volume":"3","author":"Kumar","year":"2003","journal-title":"Am J Transplant"},{"key":"2022062212370106200_cvab343-B73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.healun.2020.03.006","article-title":"First cases of COVID-19 in heart transplantation from China","volume":"39","author":"Li","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022062212370106200_cvab343-B74","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1111\/ajt.15982","article-title":"Early experience of COVID-19 in 2 heart transplant recipients: case reports and review of treatment options","volume":"20","author":"Holzhauser","year":"2020","journal-title":"Am J Transplant"},{"key":"2022062212370106200_cvab343-B75","article-title":"Characteristics and outcomes of recipients of heart transplant with coronavirus disease","author":"Latif","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.healun.2020.04.021","article-title":"COVID-19 in a pediatric heart transplant recipient: emergence of donor-specific antibodies","volume":"39","author":"Russell","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022062212370106200_cvab343-B77","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.transproceed.2020.09.006","article-title":"Effects of coronavirus disease 2019 on solid organ transplantation","volume":"52","author":"Aziz","year":"2020","journal-title":"Transplant Proc"},{"key":"2022062212370106200_cvab343-B78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2020.03.008","article-title":"Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report","volume":"39","author":"Ren","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022062212370106200_cvab343-B79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B80","author":"Dvir","year":"16 2020"},{"key":"2022062212370106200_cvab343-B81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ehjqcco\/qcaa079","article-title":"Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality","volume":"7","author":"Mohamed","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2022062212370106200_cvab343-B82","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM200008313430903","article-title":"Predictors of outcome in severe, asymptomatic aortic stenosis","volume":"343","author":"Rosenhek","year":"2000","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.109.894170","article-title":"Natural history of very severe aortic stenosis","volume":"121","author":"Rosenhek","year":"2010","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B84","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.amjcard.2013.07.025","article-title":"Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement","volume":"112","author":"Zlotnick","year":"2013","journal-title":"Am J Cardiol"},{"key":"2022062212370106200_cvab343-B85","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B86","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/eurheartj\/ehu189","article-title":"High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis","volume":"35","author":"Chin","year":"2014","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B87","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival","volume":"63","author":"Clavel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B88","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2014from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B89","doi-asserted-by":"crossref","first-page":"e2020402","DOI":"10.1001\/jamanetworkopen.2020.20402","article-title":"Mortality, stroke, and hospitalization associated with deferred vs expedited aortic valve replacement in patients referred for symptomatic severe aortic stenosis during the COVID-19 pandemic","volume":"3","author":"Ryffel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B90","doi-asserted-by":"crossref","first-page":"e2019801","DOI":"10.1001\/jamanetworkopen.2020.19801","article-title":"Characteristics and outcomes of patients deferred for transcatheter aortic valve replacement because of COVID-19","volume":"3","author":"Ro","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B91","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.13003","article-title":"Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report","author":"Attisano","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2022062212370106200_cvab343-B92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ejcts\/ezaa193","article-title":"Valve-in-valve transcatheter aortic valve replacement in a young patient with a suspected COVID-19 infection: a surgical dilemma in the era of the COVID-19 pandemic","volume":"58","author":"Bauernschmitt","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022062212370106200_cvab343-B93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2022062212370106200_cvab343-B94","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B95","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B96","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B97","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B98","doi-asserted-by":"crossref","first-page":"e006929","DOI":"10.1161\/CIRCINTERVENTIONS.118.006929","article-title":"Length of stay and discharge disposition after transcatheter versus surgical aortic valve replacement in the United States","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"2022062212370106200_cvab343-B99","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B101","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B102","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jcmg.2018.05.014","article-title":"Long-term outcome of active surveillance in severe but asymptomatic primary mitral regurgitation","volume":"11","author":"Zilberszac","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022062212370106200_cvab343-B103","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2017.09.015","article-title":"Outcomes with transcatheter mitral valve repair in the United States: an STS\/ACC TVT registry report","volume":"70","author":"Sorajja","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B104","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B105","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2022062212370106200_cvab343-B106","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"2022062212370106200_cvab343-B107","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2022062212370106200_cvab343-B108","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","article-title":"Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19","volume":"395","author":"Williams","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B109","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B110","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2022062212370106200_cvab343-B111","first-page":"m810","article-title":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19","volume":"368","author":"Sommerstein","year":"2020","journal-title":"BMJ"},{"key":"2022062212370106200_cvab343-B112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2022062212370106200_cvab343-B113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"2022062212370106200_cvab343-B114","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"2022062212370106200_cvab343-B115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2022062212370106200_cvab343-B116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B117","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B118","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"2022062212370106200_cvab343-B119","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1093\/eurheartj\/ehaa794","article-title":"Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney","volume":"41","author":"Jiang","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust","volume":"22","author":"Bean","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022062212370106200_cvab343-B121","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B122","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B123","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B124","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"2022062212370106200_cvab343-B126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022062212370106200_cvab343-B128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-2600(21)00003-5","article-title":"Renin-angiotensin system inhibitors in hospitalised patients with COVID-19","volume":"9","author":"Williams","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022062212370106200_cvab343-B129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"2022062212370106200_cvab343-B130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"2022062212370106200_cvab343-B131","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/Mas receptor axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr Drug Targets"},{"key":"2022062212370106200_cvab343-B132","year":"2 2020"},{"key":"2022062212370106200_cvab343-B133","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"key":"2022062212370106200_cvab343-B134","author":"de Simone","year":"26 2021"},{"key":"2022062212370106200_cvab343-B135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/europace\/eux091","article-title":"Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B136","doi-asserted-by":"crossref","first-page":"e2011122","DOI":"10.1001\/jamanetworkopen.2020.11122","article-title":"Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"2022062212370106200_cvab343-B138","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022062212370106200_cvab343-B139","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2022062212370106200_cvab343-B140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"key":"2022062212370106200_cvab343-B141","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"2022062212370106200_cvab343-B142","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/eurheartj\/ehaa500","article-title":"Pulmonary embolism in COVID-19 patients: a French multicentre cohort study","volume":"41","author":"Fauvel","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B143","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"2022062212370106200_cvab343-B144","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2020.06.010","article-title":"Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease?","volume":"193","author":"van Dam","year":"2020","journal-title":"Thromb Res"},{"key":"2022062212370106200_cvab343-B145","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"2022062212370106200_cvab343-B146","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B147","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1038\/nrdp.2018.28","article-title":"Pulmonary embolism","volume":"4","author":"Huisman","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2022062212370106200_cvab343-B148","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability","volume":"381","author":"Kearon","year":"2019","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B149","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(17)30885-1","article-title":"Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study","volume":"390","author":"van der Hulle","year":"2017","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa1813865","article-title":"Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism","volume":"380","author":"van der Pol","year":"2019","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B151","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B152","article-title":"Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies","author":"Hasan Ali","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022062212370106200_cvab343-B153","doi-asserted-by":"crossref","first-page":"e2017539","DOI":"10.1001\/jamanetworkopen.2020.17539","article-title":"Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19)","volume":"3","author":"Reyes Gil","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B154","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/jth.14994","article-title":"Antiphospholipid antibodies in patients with COVID-19: a relevant observation?","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2022062212370106200_cvab343-B155","author":"Cardiac Society of Australia and New Zealand. COVID-19 resources","year":"1 2020"},{"key":"2022062212370106200_cvab343-B156","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.hrthm.2020.03.028","article-title":"Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association","volume":"17","author":"Lakkireddy","year":"2020","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B157","author":"National Health Society","year":"26 2021"},{"key":"2022062212370106200_cvab343-B158","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/euaa187","article-title":"HRS\/EHRA\/APHRS\/LAHRS\/ACC\/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic","volume":"23","author":"Varma","year":"2021","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B159","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/jce.14755","article-title":"Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: lessons learned during Italian lockdown","volume":"31","author":"Piro","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022062212370106200_cvab343-B160","doi-asserted-by":"crossref","first-page":"e009121","DOI":"10.1161\/CIRCEP.120.009121","article-title":"Arrhythmic complications of patients hospitalized with COVID-19: incidence, risk factors, and outcomes","volume":"13","author":"Peltzer","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B161","doi-asserted-by":"crossref","first-page":"e13387","DOI":"10.1111\/eci.13387","article-title":"Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: a multicenter observational study","volume":"50","author":"Russo","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"2022062212370106200_cvab343-B162","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/europace\/euy110","article-title":"European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)","volume":"21","author":"Boriani","year":"2019","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B163","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia: the Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B164","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B165","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resuscitation.2015.07.038","article-title":"European Resuscitation Council Guidelines for resuscitation 2015: section 1. Executive summary","volume":"95","author":"Monsieurs","year":"2015","journal-title":"Resuscitation"},{"key":"2022062212370106200_cvab343-B167","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B168","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B169","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacep.2020.05.015","article-title":"Atrial arrhythmias in COVID-19 patients","volume":"6","author":"Colon","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2022062212370106200_cvab343-B170","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B171","doi-asserted-by":"crossref","first-page":"e009040","DOI":"10.1161\/CIRCEP.120.009040","article-title":"New-onset cardiac arrhythmias during COVID-19 hospitalization","volume":"13","author":"Iacopino","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B172","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/jce.14770","article-title":"Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19","volume":"31","author":"Peltzer","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022062212370106200_cvab343-B173","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/pace.13987","article-title":"Low prevalence of arrhythmias in clinically stable COVID-19 patients","volume":"43","author":"Sala","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022062212370106200_cvab343-B174","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jcrc.2015.06.003","article-title":"Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome","volume":"30","author":"Ambrus","year":"2015","journal-title":"J Crit Care"},{"key":"2022062212370106200_cvab343-B175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2022062212370106200_cvab343-B176","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.14-0003","article-title":"Long-term outcomes following development of new-onset atrial fibrillation during sepsis","volume":"146","author":"Walkey","year":"2014","journal-title":"Chest"},{"key":"2022062212370106200_cvab343-B177","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40256-020-00429-7","article-title":"Amiodarone in the COVID-19 era: treatment for symptomatic patients only, or drug to prevent infection?","volume":"20","author":"Sanchis-Gomar","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"2022062212370106200_cvab343-B178","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B179","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hrcr.2020.08.017","article-title":"Malignant ventricular arrhythmias in patients with severe acute respiratory distress syndrome due to COVID-19 without significant structural heart disease","volume":"6","author":"Abrams","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B180","doi-asserted-by":"crossref","first-page":"e008920","DOI":"10.1161\/CIRCEP.120.008920","article-title":"Malignant arrhythmias in patients with COVID-19: incidence, mechanisms, and outcomes","volume":"13","author":"Turagam","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B181","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1111\/jce.14772","article-title":"Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort","volume":"31","author":"Abrams","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022062212370106200_cvab343-B182","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","article-title":"Incidence and prognosis of sustained arrhythmias in critically ill patients","volume":"178","author":"Annane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2022062212370106200_cvab343-B183","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2019.04.011","article-title":"Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators","volume":"124","author":"Madjid","year":"2019","journal-title":"Am J Cardiol"},{"key":"2022062212370106200_cvab343-B184","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.hrcr.2020.03.016","article-title":"An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine","volume":"6","author":"Mitra","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacep.2015.05.008","article-title":"Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures","volume":"1","author":"Badri","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2022062212370106200_cvab343-B186","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2020.03.024","article-title":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes","volume":"17","author":"Wu","year":"2020","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B187","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B188","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.hrthm.2020.04.046","article-title":"Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019","volume":"17","author":"Szekely","year":"2020","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B189","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Group","year":"2021","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B191","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.120.048238","article-title":"Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization Pharmacovigilance Database","volume":"142","author":"Nguyen","year":"2020","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B192","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.hrthm.2020.07.001","article-title":"Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk","volume":"17","author":"Offerhaus","year":"2020","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B193","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaccas.2020.04.007","article-title":"Transient Brugada-like electrocardiographic pattern in a patient with COVID-19","volume":"2","author":"Vidovich","year":"2020","journal-title":"JACC Case Rep"},{"key":"2022062212370106200_cvab343-B194","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hrcr.2020.03.012","article-title":"COVID-19 infection unmasking brugada syndrome","volume":"6","author":"Chang","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12471-020-01459-1","article-title":"Two patients with COVID-19 and a fever-induced Brugada-like electrocardiographic pattern","volume":"28","author":"van de Poll","year":"2020","journal-title":"Neth Heart J"},{"key":"2022062212370106200_cvab343-B196","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.hrcr.2020.07.008","article-title":"Electrical storm in a febrile patient with Brugada syndrome and COVID-19 infection","volume":"6","author":"Maglione","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B197","doi-asserted-by":"crossref","first-page":"e009023","DOI":"10.1161\/CIRCEP.120.009023","article-title":"Electrocardiographic changes and arrhythmias in hospitalized patients with COVID-19","volume":"13","author":"Moey","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B198","doi-asserted-by":"crossref","first-page":"e12805","DOI":"10.1111\/anec.12805","article-title":"Electrocardiograhic characteristics in patients with coronavirus infection: a single-center observational study","volume":"25","author":"Li","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2022062212370106200_cvab343-B199","doi-asserted-by":"crossref","first-page":"e12806","DOI":"10.1111\/anec.12806","article-title":"Electrocardiogram analysis of patients with different types of COVID-19","volume":"25","author":"Wang","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2022062212370106200_cvab343-B200","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/eurheartj\/ehaa307","article-title":"Transient complete heart block in a patient with critical COVID-19","volume":"41","author":"Azarkish","year":"2020","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B201","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaccas.2020.05.023","article-title":"Complete heart block, severe ventricular dysfunction, and myocardial inflammation in a child with COVID-19 infection","volume":"2","author":"El-Assaad","year":"2020","journal-title":"JACC Case Rep"},{"key":"2022062212370106200_cvab343-B202","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.hrcr.2020.06.014","article-title":"Heart block in patients with coronavirus disease 2019: a case series of 3 patients infected with SARS-CoV-2","volume":"6","author":"Eneizat Mahdawi","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B203","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaccas.2020.04.026","article-title":"Heart brake: an unusual cardiac manifestation of COVID-19","volume":"2","author":"Kir","year":"2020","journal-title":"JACC Case Rep"},{"key":"2022062212370106200_cvab343-B204","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrcr.2020.09.003","article-title":"Atypical presentation of COVID-19 as subclinical myocarditis with persistent high-degree atrioventricular block treated with pacemaker implant","volume":"6","author":"Al-Assaf","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"2022062212370106200_cvab343-B205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa132","article-title":"Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series","volume":"4","author":"Peigh","year":"2020","journal-title":"Eur Heart J Case Rep"},{"key":"2022062212370106200_cvab343-B206","author":"World Health Organization","year":"21 2021"},{"key":"2022062212370106200_cvab343-B207","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2022062212370106200_cvab343-B208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"2022062212370106200_cvab343-B209","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022062212370106200_cvab343-B210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B211","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B212","article-title":"Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial","author":"Mitja","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022062212370106200_cvab343-B213","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19 : a randomized trial","volume":"173","author":"Skipper","year":"2020","journal-title":"Ann Intern Med"},{"key":"2022062212370106200_cvab343-B214","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19\u2014interim WHO solidarity trial results","volume":"384","author":"WHO SOLIDARITY Trial Consortium","year":"2021","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B215"},{"key":"2022062212370106200_cvab343-B216","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13063-019-3846-x","article-title":"Treatment of middle east respiratory syndrome with a combination of lopinavir\/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial","volume":"21","author":"Arabi","year":"2020","journal-title":"Trials"},{"key":"2022062212370106200_cvab343-B217","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"2022062212370106200_cvab343-B218","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022062212370106200_cvab343-B219","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B220","article-title":"Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B221","doi-asserted-by":"crossref","first-page":"e00221\u201318","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"2022062212370106200_cvab343-B222","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022062212370106200_cvab343-B223","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022062212370106200_cvab343-B224","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"2022062212370106200_cvab343-B225","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B226","author":"Joyner","year":"2020"},{"key":"2022062212370106200_cvab343-B227","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(21)01064-3","article-title":"Convalescent plasma in patients hospitalised with COVID-19","volume":"397","author":"Liu","year":"2021","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B228","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B229","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B231","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa2033130","article-title":"A neutralizing monoclonal antibody for hospitalized patients with Covid-19","volume":"384","author":"ACTIV-3\/TICO LY-CoV555 Study Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B232","author":"National Institutes of Health","year":"5 2021"},{"key":"2022062212370106200_cvab343-B233","author":"Horby","year":"2021"},{"key":"2022062212370106200_cvab343-B234","doi-asserted-by":"crossref","first-page":"13093.","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci Rep"},{"key":"2022062212370106200_cvab343-B235","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(20)31862-6","article-title":"Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial","volume":"396","author":"Furtado","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B236","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022062212370106200_cvab343-B237","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B238","author":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group"},{"key":"2022062212370106200_cvab343-B239","doi-asserted-by":"crossref","first-page":"e2013136","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B240","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"9","author":"Tardif","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022062212370106200_cvab343-B241","author":"Horby","year":"2021"},{"key":"2022062212370106200_cvab343-B242","author":"University of Liverpool","year":"2 2020"},{"key":"2022062212370106200_cvab343-B243","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of multi-ion channel block in a phase I randomized study design: results of the CiPA phase I ECG biomarker validation study","volume":"105","author":"Vicente","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2022062212370106200_cvab343-B244","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10840-020-00822-x","article-title":"QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin","volume":"59","author":"Hsia","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"2022062212370106200_cvab343-B245","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pctr.0020006","article-title":"Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers","volume":"2","author":"Mzayek","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"2022062212370106200_cvab343-B246","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12471-020-01462-6","article-title":"The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine","volume":"28","author":"Sinkeler","year":"2020","journal-title":"Neth Heart J"},{"key":"2022062212370106200_cvab343-B247","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/eut290","article-title":"Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus","volume":"16","author":"Teixeira","year":"2014","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B248","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","volume":"28","author":"van den Broek","year":"2020","journal-title":"Neth Heart J"},{"key":"2022062212370106200_cvab343-B249","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/0961203306lu2345oa","article-title":"The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"2022062212370106200_cvab343-B250","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022062212370106200_cvab343-B251","doi-asserted-by":"crossref","first-page":"e008662","DOI":"10.1161\/CIRCEP.120.008662","article-title":"Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B252","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0066-782X2002001000009","article-title":"Cardiac damage from chronic use of chloroquine: a case report and review of the literature","volume":"79","author":"Teixeira","year":"2002","journal-title":"Arq Bras Cardiol"},{"key":"2022062212370106200_cvab343-B253","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"2022062212370106200_cvab343-B254","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cjca.2014.08.016","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"key":"2022062212370106200_cvab343-B255","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.hrthm.2015.05.027","article-title":"Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: novel electrophysiological insights and therapeutic potential","volume":"12","author":"Capel","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022062212370106200_cvab343-B256","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/europace\/euaa216","article-title":"Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings","volume":"22","author":"Gasperetti","year":"2020","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B257","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4070\/kcj.2010.40.11.604","article-title":"A case of chloroquine-induced cardiomyopathy that presented as sick sinus syndrome","volume":"40","author":"Lee","year":"2010","journal-title":"Korean Circ J"},{"key":"2022062212370106200_cvab343-B258","first-page":"545","article-title":"Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus","volume":"36","author":"McGhie","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2022062212370106200_cvab343-B259","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2022062212370106200_cvab343-B260","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"5","author":"Bessi\u00e8re","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B261","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022062212370106200_cvab343-B262","doi-asserted-by":"crossref","first-page":"e017144","DOI":"10.1161\/JAHA.120.017144","article-title":"Experience with hydroxychloroquine and azithromycin in the coronavirus disease 2019 pandemic: implications for QT interval monitoring","volume":"9","author":"Ramireddy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022062212370106200_cvab343-B263","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B264","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.hroo.2020.06.002","article-title":"QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019","volume":"1","author":"Sridhar","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"2022062212370106200_cvab343-B265","doi-asserted-by":"crossref","first-page":"e008937","DOI":"10.1161\/CIRCEP.120.008937","article-title":"Safely administering potential QTc prolonging therapy across a large health care system in the COVID-19 era","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022062212370106200_cvab343-B266","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12012-017-9401-7","article-title":"Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin","volume":"17","author":"Zhang","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"2022062212370106200_cvab343-B267","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B268","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11531850-000000000-00000","article-title":"Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System","volume":"33","author":"Poluzzi","year":"2010","journal-title":"Drug Saf"},{"key":"2022062212370106200_cvab343-B269","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The role of macrolide antibiotics in increasing cardiovascular risk","volume":"66","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B270","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0897190013516503","article-title":"Azithromycin and the risk of cardiovascular complications","volume":"27","author":"Maisch","year":"2014","journal-title":"J Pharm Pract"},{"key":"2022062212370106200_cvab343-B271","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/14740338.2015.989210","article-title":"Cardiac risks associated with antibiotics: azithromycin and levofloxacin","volume":"14","author":"Lu","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"2022062212370106200_cvab343-B272","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"key":"2022062212370106200_cvab343-B273","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2020.10.028","article-title":"Spontaneous reported cardiotoxicity induced by lopinavir\/ritonavir in COVID-19. An alleged past-resolved problem","volume":"324","author":"Fresse","year":"2021","journal-title":"Int J Cardiol"},{"key":"2022062212370106200_cvab343-B274","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1310\/hct1005-328","article-title":"Electrocardiogram abnormalities with atazanavir and lopinavir\/ritonavir","volume":"10","author":"Rathbun","year":"2009","journal-title":"HIV Clin Trials"},{"key":"2022062212370106200_cvab343-B275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00380-020-01671-4","article-title":"Effects on QT interval of hydroxychloroquine associated with ritonavir\/darunavir or azithromycin in patients with SARS-CoV-2 infection","volume":"36","author":"Moschini","year":"2021","journal-title":"Heart Vessels"},{"key":"2022062212370106200_cvab343-B276","doi-asserted-by":"crossref","first-page":"648","DOI":"10.5414\/CP201549","article-title":"Thorough QT\/QTc study of tocilizumab after single-dose administration at therapeutic and supratherapeutic doses in healthy subjects","volume":"49","author":"Grange","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2022062212370106200_cvab343-B277","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","article-title":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19","volume":"181","author":"Gupta","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2022062212370106200_cvab343-B278","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2020.6820","article-title":"Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial","volume":"181","author":"Hermine","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2022062212370106200_cvab343-B279","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2022062212370106200_cvab343-B280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.msard.2017.10.020","article-title":"Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis","volume":"19","author":"Akbulak","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"2022062212370106200_cvab343-B281","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00415-013-7115-8","article-title":"Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study","volume":"261","author":"Gold","year":"2014","journal-title":"J Neurol"},{"key":"2022062212370106200_cvab343-B282","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12883-016-0789-7","article-title":"Electrocardiographic assessments and cardiac events after fingolimod first dose\u2014a comprehensive monitoring study","volume":"17","author":"Limmroth","year":"2017","journal-title":"BMC Neurol"},{"key":"2022062212370106200_cvab343-B283","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12883-019-1506-0","article-title":"Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic","volume":"19","author":"Brown","year":"2019","journal-title":"BMC Neurol"},{"key":"2022062212370106200_cvab343-B284","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cts.12840","article-title":"Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects","volume":"13","author":"Humeniuk","year":"2020","journal-title":"Clin Transl Sci"},{"key":"2022062212370106200_cvab343-B285","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"2022062212370106200_cvab343-B286","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"2022062212370106200_cvab343-B287","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2020-218479","article-title":"Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study","volume":"79","author":"Ramiro","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022062212370106200_cvab343-B288","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijid.2020.09.1486","article-title":"Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness","volume":"101","author":"Rubio-Rivas","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2022062212370106200_cvab343-B289","first-page":"47","article-title":"Bradycardia following oral corticosteroid use: case report and literature review","volume":"5","author":"Al Shibli","year":"2012","journal-title":"Arab J Nephrol Transplant"},{"key":"2022062212370106200_cvab343-B290","doi-asserted-by":"crossref","first-page":"117954761983102","DOI":"10.1177\/1179547619831026","article-title":"Acute symptomatic sinus bradycardia in high-dose methylprednisolone therapy in a woman with inflammatory myelitis: a case report and review of the literature","volume":"12","author":"Sodero","year":"2019","journal-title":"Clin Med Insights Case Rep"},{"key":"2022062212370106200_cvab343-B291","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2022062212370106200_cvab343-B292","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.93.3.407","article-title":"Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence","volume":"93","author":"Yang","year":"1996","journal-title":"Circulation"},{"key":"2022062212370106200_cvab343-B293","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jce.12976","article-title":"Comparison of QT interval readings in normal sinus rhythm between a smartphone heart monitor and a 12-lead ECG for healthy volunteers and inpatients receiving sotalol or dofetilide","volume":"27","author":"Garabelli","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022062212370106200_cvab343-B294","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B295","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B296","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B297","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2022062212370106200_cvab343-B298","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"2022062212370106200_cvab343-B299","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062212370106200_cvab343-B300","author":"Medscape"},{"key":"2022062212370106200_cvab343-B301","author":"Faragon","year":"26 2021"},{"key":"2022062212370106200_cvab343-B302","article-title":"2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"2022062212370106200_cvab343-B303","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40262-017-0554-0","article-title":"An open-label crossover study of the pharmacokinetics of the 60-mg edoxaban tablet crushed and administered either by a nasogastric tube or in apple puree in healthy adults","volume":"57","author":"Duchin","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"2022062212370106200_cvab343-B304","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpdd.123","article-title":"Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube","volume":"3","author":"Moore","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2022062212370106200_cvab343-B305","first-page":"1674","article-title":"Evaluation of crushed tablet for oral administration and the effect of food on apixaban pharmacokinetics in healthy adults","volume-title":"Clin Ther","author":"Song","year":"2016"},{"key":"2022062212370106200_cvab343-B306","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.clinthera.2015.05.497","article-title":"Relative bioavailability of apixaban solution or crushed tablet formulations administered by mouth or nasogastric tube in healthy subjects","volume":"37","author":"Song","year":"2015","journal-title":"Clin Ther"},{"key":"2022062212370106200_cvab343-B307","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJMp2002125","article-title":"Defining the epidemiology of Covid-19\u2014studies needed","volume":"382","author":"Lipsitch","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B308","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair allocation of scarce medical resources in the time of Covid-19","volume":"382","author":"Emanuel","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B309","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe Covid-19 with respiratory failure","volume":"383","author":"Severe Covid-19 GWAS Group","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B310","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s40615-020-00756-0","article-title":"The COVID-19 pandemic: a call to action to identify and address racial and ethnic disparities","volume":"7","author":"Laurencin","year":"2020","journal-title":"J Racial Ethn Health Disparities"},{"key":"2022062212370106200_cvab343-B311","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1056\/NEJMp2021264","article-title":"Covid-19 and disparities in nutrition and obesity","volume":"383","author":"Belanger","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B312","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1056\/NEJMp2023616","article-title":"Structural racism, social risk factors, and Covid-19\u2014a dangerous convergence for Black Americans","volume":"383","author":"Egede","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B313","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and mortality among black patients and white patients with Covid-19","volume":"382","author":"Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"key":"2022062212370106200_cvab343-B314","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"2022062212370106200_cvab343-B315","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022062212370106200_cvab343-B316","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjsports-2018-100324","article-title":"Effect of interventions using physical activity trackers on physical activity in people aged 60 years and over: a systematic review and meta-analysis","volume":"54","author":"S Oliveira","year":"2020","journal-title":"Br J Sports Med"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvab343\/41469039\/cvab343.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/7\/1618\/44162453\/cvab343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/7\/1618\/44162453\/cvab343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:39:01Z","timestamp":1699875541000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/118\/7\/1618\/6448161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":316,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2022,6,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvab343","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,15]]},"published":{"date-parts":[[2021,12,2]]}}}